ArticleClinical cancer research : an official journal of the American Association for Cancer Research2014

VEGF/VEGFR-2 upregulates EZH2 expression in lung adenocarcinoma cells and EZH2 depletion enhances the response to platinum-based and VEGFR-2-targeted therapy.

Erick Riquelme et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.